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ABSTRACT The spleen tyrosine kinase (Syk) and the downstream adaptor protein
CARD9 are crucial signaling molecules in antimicrobial immunity. Candida parapsilosis
is an emerging fungal pathogen with a high incidence in neonates, while Candida albi-
cans is the most common agent of candidiasis. While signaling through Syk/CARD9
promotes protective host mechanisms in response to C. albicans, its function in immu-
nity against C. parapsilosis remains unclear. Here, we generated Syk2/2 and CARD92/2
bone marrow chimeric mice to study the role of Syk/CARD9 signaling in immune
responses to C. parapsilosis compared to C. albicans. We demonstrate various functions
of this pathway (e.g., phagocytosis, phagosome acidification, and killing) in Candida-
challenged, bone marrow-derived macrophages with differential involvement of Syk
and CARD9 along with species-specific differences in cytokine production. We report
that Syk2/2 or CARD92/2 chimeras rapidly display high susceptibility to C. albicans,
while C. parapsilosis infection exacerbates over a prolonged period in these animals.
Thus, our results establish that Syk and CARD9 contribute to systemic resistance to C.
parapsilosis and C. albicans differently. Additionally, we confirm prior studies but also
detail new insights into the fundamental roles of both proteins in immunity against C.
albicans. Our data further suggest that Syk has a more prominent influence on anti-
Candida immunity than CARD9. Therefore, this study reinforces the Syk/CARD9 path-
way as a potential target for anti-Candida immune therapy.
IMPORTANCE While C. albicans remains the most clinically significant Candida species,
C. parapsilosis is an emerging pathogen with increased affinity to neonates. Syk/CARD9
signaling is crucial in immunity to C. albicans, but its role in in vivo responses to other
pathogenic Candida species is largely unexplored. We used mice with hematopoietic
systems deficient in Syk or CARD9 to comparatively study the function of these proteins
in anti-Candida immunity. We demonstrate that Syk/CARD9 signaling has a protec-
tive role against C. parapsilosis differently than against C. albicans. Thus, this study
is the first to reveal that Syk can exert immune responses during systemic Candida
infections species specifically. Additionally, Syk-dependent immunity to a nonalbicans
Candida species in an in vivo murine model has not been reported previously. We
highlight that the contribution of Syk and CARD9 to fungal infections are not identical
and underline this pathway as a promising immune-therapeutic target to fight Candida
infections.
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Advancements in the study of antifungal immunity have revealed variousapproaches to promote recovery from fungal diseases through the modulation of
immune responses. Although adjunctive antifungal immune therapies signify a promising
direction in aiding the efficiency of antimycotic drugs, several challenges hinder their de-
velopment (1–3). One difficulty is that taxonomically close species may induce dissimilar
immune responses.
Invasive Candida infections have a worldwide annual incidence of ;700.000 (4),
and they are associated with a mortality of ;30 to 75% (5, 6). Although C. albicans is
the most frequent agent, C. parapsilosis has a record of globally increasing incidence,
and it poses a particular threat to neonates and patients on parenteral nutrition (6–9).
The two species may induce different host responses. For instance, C. albicans favors
the polarization of Th cells to the Th17 phenotype more efficiently than C. parapsilosis
in cell culture (10). Also, unlike C. albicans, C. parapsilosis triggers prominent interleukin
27 (IL-27) production to suppress protective inflammatory processes in mice. Therefore, the
notion of therapeutically blocking IL-27 signaling during C. parapsilosis infections has been
raised, underlining the need to identify species-specific immune reactions (11). The differences
between the immunogenicity of the two species arise partially from their nonidentical mor-
phology, cell wall composition, and interaction with pattern recognition receptors (PRRs) (12).
A major function of the spleen tyrosine kinase (Syk) is to mediate signaling initiated by
PRRs (e.g., Dectin-1) binding microbial structures (13, 14), especially fungal pathogen-associ-
ated molecular patterns (15–17). A major pathway proceeding through PKCd and Vav pro-
teins (18, 19) relies on the downstream adaptor caspase recruitment domain-containing pro-
tein 9 (CARD9), which functions as a component of supramolecular structures such as the
CARD9-BCL10-MALT-1 or the CARD9-H-Ras-Ras-GRF1 complexes (20–22). Nevertheless, Syk
and CARD9 can operate independently (23, 24). Upon fungal stimuli, the Syk/CARD9 path-
way results in the activation of innate antifungal mechanisms that may later shape adaptive
immunity (23, 25–33). Consequently, deficiency in Syk/CARD9 signaling increases susceptibil-
ity to invasive fungal infections in both humans and mice (21, 25, 26, 28, 33–36). For exam-
ple, CARD9 mutations have been associated with chronic mucocutaneous candidiasis,
meningoencephalitis, and colitis caused by C. albicans (26, 34, 35). Although multiple studies
have underlined the pivotal role of Syk and CARD9 in immunity against C. albicans (21, 25,
26, 28, 33, 37), several findings are conferred only from chemical inhibition of Syk activity or
the use of artificial yeast mimics (e.g., zymosan or heat-killed cells). In contrast, the only direct
link between this pathway and C. parapsilosis-induced immune responses is the compro-
mised IL-1b production of Syk-blocked THP-1 cells after fungal challenge (38).
In this study, we aimed to ascertain if Syk/CARD9 signaling is a prominent compo-
nent of immunity to C. parapsilosis. We demonstrate that this pathway is involved in
various immune responses evoked by C. parapsilosis in bone marrow-derived macrophages
(BMDMs). Utilizing Syk- or CARD9-deficient bone marrow chimeric mice (referred to as Syk2/2
or CARD92/2 chimeras and the respective wild-type controls as WtSyk and WtCARD9 chimeras),
we also provide evidence that this pathway confers protection in the setting of invasive
C. parapsilosis infection, which becomes especially apparent in the late phase of the infection.
As most experiments were carried out in comparison with live C. albicans, we confirm previous
studies and provide new insights into the essential roles of Syk and CARD9 in immunity
against this pathogen. Finally, we demonstrate that this signaling pathway is differentially
involved in mediating protection against the two Candida species in vivo.
RESULTS
Syk and CARD9 mediate nuclear translocation of NF-jB p65 in C. parapsilosis-
treated BMDMs. The classical activation of the NF-kB pathway through nuclear trans-
location of the p65 subunit is a major component of antifungal immunity (39–41).
Recently, C. parapsilosis was shown to trigger this translocation in THP-1 cells (42). However, it
is unclear whether Syk or CARD9 controls this process. Therefore, we implemented immune
staining of p65 to monitor its translocation in C. parapsilosis-infected (strains GA1, CLIB214,
and CDC317) BMDMs cultured fromWtSyk, Syk2/2, WtCARD9, and CARD92/2 chimeras. We found
a decreased proportion of Syk2/2 or CARD92/2 macrophages with p651 nuclei compared to
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WtSyk or WtCARD9 cells, respectively, in case of all strains (mean6 SD of percent decrease com-
pared to wild-type [WT] control cells; Syk2/2, GA1, 51.06 6 23.40; CLIB214, 31.89 6 11.35;
CDC314, 39.33 6 15.40; CARD92/2, GA1, 44.75 6 26.56; CLIB214, 26.58 6 22.29; CDC314,
49.89 6 26.03) (Fig. 1). Lipopolysaccharide (LPS)-induced NF-kB activation served as positive
control, with over 60% of BMDMs displaying p65 translocation regardless of genetic back-
ground (Fig. 1). These findings suggest that activation of NF-kB in C. parapsilosis-infected
BMDMs is under the influence of the Syk/CARD9 pathway.
The Syk/CARD9 pathway differentially controls cytokine production of BMDMs
in response to C. parapsilosis and C. albicans. The involvement of Syk and CARD9 in
NF-kB regulation suggested that the consequent cytokine production would also
depend on these proteins during C. parapsilosis infection. Therefore, we assessed the cytokine
response of WtSyk, Syk2/2, WtCARD9, and CARD92/2 BMDMs following fungal stimuli.
First, we used proteome profiler membranes to identify cytokines in cell culture superna-
tants collected from BMDMs challenged with the GA1 strain. In the case of WtSyk and WtCARD9
BMDMs, tumor necrosis factor alpha (TNF-a), and chemokines KC (CXCL1), MIP-1a (CCL3),
and MIP-2 (CXCL2) were detected (Fig. S1 in the supplemental material). Compared to the
WT BMDMs, the TNF-a yield from Syk2/2 or CARD92/2 cells was diminished after the fungal
challenge. While the chemokine secretion of Syk2/2 BMDMs appeared intact (Fig. S1A),
CARD92/2 cells secreted hardly any or no detectable KC, MIP-1a, and MIP-2 compared to
the corresponding WT cells (Fig. S1B). These cytokines were not detected in the supernatants
of uninfected control BMDMs from any genetic background (data not shown).
Next, we sought to test these observations with enzyme-linked immunosorbent assay
(ELISA), including multiple C. parapsilosis strains (GA1, CLIB214, and CDC317) and the SC5314
C. albicans strain as reference (Fig. 2 and Table S1). The TNF-a production of C. parapsilosis-
or C. albicans-treated Syk2/2 or CARD92/2 macrophages was lower than that of WtSyk and
WtCARD9 cells by .42% (Fig. 2A and B). While the chemokine yield of C. albicans-stimulated
Syk2/2 macrophages dropped by ;90% in comparison to WtSyk BMDMs, the KC, MIP-1a,
and MIP-2 expression of C. parapsilosis-treated Syk2/2 BMDMs did not decrease (Fig. 2C, D,
and E). In contrast, we found a decrease of at least 25% in the chemokine production of
Candida-infected CARD92/2 BMDMs (with the exception of CLIB214 for MIP-1a production)
(Fig. 2F, G, and H). Notably, the dependence of the production of any studied cytokines on
either Syk or CARD9 was greatest in the case of the C. albicans strain (Fig. 2A to H).
Taken together, we concluded that both Syk and CARD9 participate in the regulation of
cytokine production of BMDMs upon both C. parapsilosis and C. albicans infection, but the
involvement of Syk differs between the two Candida species.
FIG 1 Nuclear translocation of NF-kB p65 in BMDMs upon C. parapsilosis infection. (A and B) BMDMs were treated with C.
parapsilosis (strains GA1, CLIB214, and CDC317; MOI of 5:1) or LPS (1 mg/ml) for 90 min, or untreated control (ctr) cells
were used. Nuclei were stained with DRAQ5 and NF-kB p65 with an Alexa Fluor 488-conjugated antibody. Cells were
analyzed by imaging flow cytometry. Percentage of WtSyk, Syk
2/2 (A), WtCARD9, and CARD9
2/2 (B) BMDMs with p651 nuclei
are shown. Data represent the mean 6 SD. Data are pooled from a minimum of 4 independent experiments. The paired
Student's t test was applied. *, P , 0.05.
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FIG 2 Cytokine production of BMDMs upon C. parapsilosis or C. albicans infection. (A to H) WtSyk, Syk
2/2 (A, C, D, and E), WtCARD9, and
CARD92/2 (B, F, G, and H) BMDMs were treated with C. parapsilosis (strains GA1, CLIB214 and CDC317; MOI of 5:1) or C. albicans (strain
SC5314; MOI of 1:25) for 24 h. Cell culture supernatants were analyzed for TNF-a (A and B), KC (C and F), MIP-1a (D and G), and MIP-2 (E
and H) by ELISA. Percentages of WT control values are shown here, while absolute concentrations are listed in Table S1 in the
supplemental material. Data represent the mean 6 SD. Data are pooled from a minimum of 4 independent experiments. The paired
Student's t test was applied. *, P , 0.05; **, P , 0.01; ***, P , 0.001; ****, P , 0.0001. Cytokine production measured by proteome
profiler membranes is shown in Fig. S1.
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Syk, but not CARD9, promotes phagocytosis of C. parapsilosis and C. albicans by
BMDMs and subsequent phagosome acidification. PRRs exploiting the Syk/CARD9
pathway have been indicated as mediators of phagocytosing fungal elements (15, 43–
45). Additionally, heat-killed Candida cells were shown to be ingested in a Syk-depend-
ent manner by neutrophils (46). As C. parapsilosis and C. albicans cells contain motives
recognized by Syk/CARD9-dependent receptors, we hypothesized that internalization
of the live form of these yeasts by macrophages was also regulated by this pathway.
Therefore, we infected BMDMs with fluorescently labeled (Alexa Fluor 488 or green
fluorescent protein [GFP]) C. parapsilosis or C. albicans cells to monitor their uptake using
imaging flow cytometry. Early (15 min) and late (120 and 30 min for C. parapsilosis and C.
albicans, respectively) experimental time points were selected. The proportion of phago-
cytosis-positive WtSyk macrophages significantly exceeded that of Syk2/2 cells regardless of
Candida species or incubation time (Fig. 3A). Furthermore, the average number of ingested
yeast cells/BMDM within the phagocytosing population was significantly higher in WtSyk cells
than in Syk2/2 macrophages in the case of the GA1 and CDC317 C. parapsilosis strains at the
late time point. A trend of nonsignificant decrease of this parameter was also detectable in
CLIB214- or SC5314-treated Syk2/2 BMDMs at this time point (Fig. 3B). In contrast, CARD92/2
cells phagocytosed both C. parapsilosis and C. albicans as effectively as their WtCARD9
counterparts (Fig. 3C and D). Thus, we concluded that Syk, but not CARD9, contributes to
the ingestion of both live C. parapsilosis and C. albicans by BMDMs.
As Syk was involved in the acidification of phagosomes containing heat-killed C.
albicans in RAW cells (31, 47), our next step was testing if phagosome acidification fol-
lowing the phagocytosis of live C. parapsilosis and C. albicans also relies on this path-
way in BMDMs. To this end, we double labeled C. parapsilosis and C. albicans cells with
Alexa Fluor 488 or GFP together with pHrodo Red, a pH-sensitive dye that gains fluo-
rescence upon acidification of phagosomes. Following coincubation with BMDMs, the
Alexa Fluor 4881/GFP1 and pHrodo Red1 macrophage populations were examined to
determine the efficiency of phagosome acidification. Relative to WtSyk cells, phago-
some acidification was less efficient in Syk2/2 cells after coincubation with any of the
applied strains (Fig. 3E). In contrast, phagosome acidification was unaltered in
CARD92/2 BMDMs (Fig. 3F). Therefore, the acidification of phagosomes containing C.
parapsilosis or C. albicans is mediated by Syk, but not CARD9, in BMDMs.
Syk, but not CARD9, plays a role in the killing of C. parapsilosis by BMDMs. Previous
studies revealed that the Syk/CARD9 signal transduction may modulate the candidaci-
dal activity of phagocytes or intracellular replication of Candida cells within innate
immune cells (15, 26, 36, 48–50). Also, our current findings show that the phagocytosis
of C. parapsilosis by murine macrophages and the subsequent phagosome acidification
is regulated by Syk. Thus, we speculated that Syk2/2, but not CARD92/2, macrophages
would be defective in the elimination of C. parapsilosis cells.
Therefore, we compared the killing efficacy of WT and mutant macrophages. Truly,
Syk2/2 BMDMs displayed diminished killing efficiency against C. parapsilosis, although the
reduction only followed a nonsignificant (P = 0.0726) trend in the case of the CDC317 strain
(Fig. 4A). As expected, CARD92/2 BMDMs eliminated C. parapsilosis similarly to WtCARD9
BMDMs (Fig. 4B).
Therefore, killing of C. parapsilosis is regulated by Syk, but not CARD9, in BMDMs.
Susceptibility of Syk2/2 or CARD92/2 bone marrow chimeric mice to C. parapsilosis
and C. albicans follows dissimilar patterns.As our in vitro studies revealed the participa-
tion of Syk/CARD9 signaling in the immune recognition of C. parapsilosis, we hypothesized
that the absence of either Syk or CARD9 in hematopoietic cells would compromise host im-
munity upon systemic C. parapsilosis infections. To test this, we challenged Syk2/2, CARD92/2,
and their corresponding WT control bone marrow chimeric mice with the C. parapsilosis GA1
strain via intravenous (i.v.) injection. C. albicans SC5314 was used as a reference strain. Fungal
burden in C. parapsilosis-treated animals was evaluated 2, 5, 7, and 30 days postinfection
(dpi). As injection of Syk2/2 or CARD92/2 chimeras with C. albicans was lethal by 4 dpi (data
not shown), fungal burden was determined at 2 dpi. At this time, no significant difference was
detected between the C. parapsilosis-challenged WtSyk and Syk2/2 or WtCARD9 and CARD92/2
Syk/CARD9 Protects from Candida Species-Specifically ®

























































chimeras in terms of blood, liver, and brain tissue colonization (Fig. 5A and B). However,
fungal burden in the spleen and kidneys of Syk2/2 chimeras was ;2.2-fold and ;1.7-fold
higher, respectively, than in WtSyk animals (Fig. 5A). Likewise, ;2.7-fold and ;2-fold higher
colonization was detected in the spleen and kidneys of C. parapsilosis-infected CARD92/2
FIG 3 BMDM phagocytosis efficiency and phagosome acidification upon C. parapsilosis or C. albicans infection. (A to D)
WtSyk, Syk
2/2 (A and B), WtCARD9, and CARD9
2/2 (C and D) BMDMs were treated with fluorescent (Alexa Fluor 488/GFP) C.
parapsilosis (strains GA1, CLIB214, and CDC317; MOI of 5:1) for 15 min and 2 h or with C. albicans (strain SC5314; MOI of 5:1)
for 15 and 30 min. Phagocytosis was assessed by imaging flow cytometry. Percentages of phagocytosis-positive macrophages
(A and C) and the mean number of ingested yeasts per macrophage (B and D) within the phagocytosing population are
shown. (E and F) WtSyk, Syk
2/2 (E), WtCARD9, and CARD9
2/2 (F) BMDMs were treated with double-labeled (Alexa Fluor 488/GFP
plus pHrodo Red) C. parapsilosis or C. albicans (MOI of 5:1) for 15 min. Efficacy of phagosome acidification was determined by
imaging flow cytometry. Data represent the mean 6 SD. Data are pooled from a minimum of 3 independent experiments.
The paired Student's t test was applied. *, P , 0.05; **, P , 0.01.
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chimeras compared to their WT counterparts (Fig. 5B). At later time intervals, C. parapsilosis
colonization of all examined organs of the Syk2/2 or CARD92/2 chimeras exceeded that of
the respective WT chimeras in most cases (Fig. 5A and B). The difference was most appa-
rent at 30 dpi where fungal burden was over 58-fold (brain), 310-fold (liver), and 3,100-fold
FIG 5 Susceptibility to systemic C. parapsilosis and C. albicans infection. (A to D) WtSyk, Syk
2/2 (A and C), WtCARD9, and CARD9
2/2 (B and D) bone marrow
chimeric mice were infected i.v. with C. parapsilosis GA1 (2  107 yeast cells/mouse) (A and B) or C. albicans SC5314 (105 yeast cells/mouse) (C and D).
Animals were euthanized at 2, 5, 7, or 30 (A and B) dpi. Blood or spleen, kidney, liver, and brain homogenates were plated on YPD plates, and CFU were
determined 2 days later. Data are pooled from at least 2 independent experiments. The Mann-Whitney test was applied. *, P , 0.05; **, P , 0.01; ***,
P , 0.001; ****, P , 0.0001; ns, not significant.
FIG 4 Killing efficacy of macrophages upon C. parapsilosis infection. (A and B) WtSyk, Syk
2/2 (A), WtCARD9, and
CARD92/2 (B) BMDMs were treated with C. parapsilosis (strains GA1, CLIB214, and CDC317; MOI of 5:1) for 3 h.
Killing efficacy was determined by CFU counting. Data represent the mean 6 SD. Data are pooled from a
minimum of 3 independent experiments. The paired Student's t test was applied. *, P , 0.05; **, P , 0.01.
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(kidneys) higher in Syk2/2 chimeras than in WtSyk chimeras (Fig. 5A). At this time, over 270
times higher colonization was determined in the kidneys of CARD92/2 chimeric mice than
WtCARD9 controls (Fig. 5B). Also, while C. parapsilosis was cleared from the brain of all
WtCARD9 chimeras, the mean fungal burden in this organ was 2,700 CFU/g in the CARD92/2
genotype (Fig. 5B). Additionally, kinetic patterns suggested that the tendency toward an
initial clearance was reversed by 30 dpi in the spleen, liver, and kidneys of Syk2/2 and the
kidneys of CARD92/2 chimeras (Fig. 5A and B). Moreover, 2 of the C. parapsilosis-infected
Syk2/2 chimeras were euthanized before day 30 due to deteriorated health conditions. The
kidneys of these animals were severely deformed by sizable abscesses full of yeast cells
(Fig. S2). However, macroscopic renal abscesses were not seen on the kidneys of any other
C. parapsilosis-infected mice.
In contrast to the C. parapsilosis challenge at 2 dpi, significantly higher fungal burdens
were detected in all inspected organs of C. albicans-treated Syk2/2 or CARD92/2 chimeras
than the corresponding WT mice (Fig. 5C and D). The difference was most prominent in the
kidneys (.200-fold), which also manifested in small abscesses in both the Syk2/2 and
CARD92/2 backgrounds (Fig. S3A and B). Nonetheless, no C. albicans colonies were recov-
ered from the blood in any genetic background (data not shown).
As kidneys are the main target organs of systemic candidiasis in mice (51, 52) and our
CFU data indicated marked differences in this organ between the Syk2/2 or CARD92/2 and
WT chimeras, we examined the presence of fungal elements and associated leukocyte infil-
trates in the kidneys using periodic acid-Schiff (PAS)-stained histological tissue sections at 2
and 30 dpi (Fig. 6 and Fig. S4A). At 2 dpi, yeast cells or leukocytes were only sporadically de-
tectable in C. parapsilosis-treated mice of any genetic background (Fig. 6A and B). While C.
FIG 6 Histopathology of kidneys during C. parapsilosis and C. albicans infection. WtSyk, Syk
2/2(A and C) WtCARD9, and CARD9
2/2 (B and D) bone marrow
chimeric mice were infected i.v. with C. parapsilosis GA1 (2  107 yeast cells/mouse) or C. albicans SC5314 (105 yeast cells/mouse) or mock infected with
PBS (see Fig. S4A) and euthanized at 2 (A and B) or 30 (C and D) dpi. PAS-stained histological sections were prepared to monitor fungal elements (white
arrows) and leukocyte infiltrates (black arrows). Scale, 100 mm. Kidney morphology of C. parapsilosis- or C. albicans-infected mice at 2 dpi are depicted in
Fig. S2, while pathological features of a C. parapsilosis Syk2/2 chimera euthanized at 26 dpi due to severe health conditions are shown in Fig. S3.
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albicans hyphae/yeast cells and immunocyte clusters were sometimes observed in the kid-
neys of WT chimeras, extensive patches occupied by fungal structures mingling with infiltrat-
ing leukocytes and necrotic tissues were conspicuous in the kidneys of Syk2/2 or CARD92/2
chimeras at 2 dpi (Fig. 6A and B). At day 30, yeast cells or frequent leukocyte infiltrates were
not characteristic of C. parapsilosis-infected WT chimeras but were observed in Syk2/2 and
CARD92/2 chimeras with detectable tissue necrosis in Syk2/2 chimeras (Fig. 6C and D).
Nevertheless, while immune cells and C. parapsilosis yeast clusters were always present in the
kidneys of Syk2/2 chimeras, these traits were not always detected in CARD92/2 chimeras.
Therefore, the absence of Syk or CARD9 in the hematopoietic cell population led to
increased susceptibility to C. parapsilosis invasive infection. However, unlike in the case
of C. albicans, massive fungal growth occurred only at a later stage of infection.
Rapid inflammation in C. albicans-infected, but not in C. parapsilosis-infected,
kidneys of Syk2/2 or CARD92/2 bone marrow chimeric mice. As leukocyte infiltrates
were plentiful in the kidneys of C. albicans-infected, but not C. parapsilosis-infected,
Syk2/2 or CARD92/2 chimeras at 2 dpi, we aimed to further characterize this inflammatory
response in this organ. We found that mainly neutrophilic granulocytes occupied these areas
as implied by expansive myeloperoxidase (MPO)-positive staining localized to infected sites
(Fig. 7 and Fig. S4A). As noted, however, leukocyte infiltrates were present in the kidneys of
C. parapsilosis-infected Syk2/2 or CARD92/2 chimeras at 30 dpi. At this time, we found that
neutrophils localized to infected sites were abundant in the kidneys of both mutant chime-
ras with CD681 macrophages and CD31 T cells also recruited to the tissues. However, these
cell populations were not as consistent in CARD92/2 chimeras as in Syk2/2 chimeras (Fig. 8B
and Fig. S4B). At 2 dpi, inflammation was also detected by ELISA in the kidneys of C. albi-
cans-infected Syk2/2 or CARD92/2 chimeras, as kidney homogenates demonstrated an
induction of IL-6, IL-1a, IL-1-b , TNF-a, and monocyte chemoattractant protein 1 (MCP-1)
production, although only IL-6 and IL-1-a concentrations were significantly higher in the
Syk2/2 than in the WtSyk background (Fig. 9A, D, G, H, I, J, and K). In contrast, C. parapsilo-
sis did not induce prominent production of these proinflammatory cytokines in any
genetic background at 2 dpi (Fig. 9). At 30 dpi, however, inflammation in the kidneys of
C. parapsilosis-challenged Syk2/2 or CARD92/2 chimeras was also confirmed by ELISA.
While the amounts of TNF-a, MCP-1, IL-1a, and IFN-gwere higher in Syk2/2 than in WtSyk
chimeric animals, only increased IL-1a and IFN-g responses were observed in C. parapsilo-
sis-infected CARD92/2 chimeras (Fig. 9B, C, D, F, J, L).
Taken together, these data indicate that, while the absence of Syk or CARD9 in the he-
matopoietic cell population leads to an early, intense inflammatory response to C. albicans
FIG 7 Presence of MPO in histological kidney sections at 2 dpi. WtSyk, Syk
2/2, WtCARD9, and CARD9
2/2 bone marrow chimeric mice were infected i.v. with C.
parapsilosis (2  107 yeast cells/mouse) or C. albicans (105 yeast cells/mouse) or mock infected with PBS (see Fig. S4), and animals were euthanized at
2 dpi. Immune staining for MPO (brown) was implemented to detect neutrophil granulocytes. Black arrows indicate positivity for MPO staining. Scale, 100 mm.
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infection, C. parapsilosis triggers a mostly delayed Syk-dependent and moderately CARD9-
dependent response in the kidneys of chimeric mice.
DISCUSSION
In this study, we used bone marrow chimeric mice to define the involvement of Syk
and CARD9 in immune responses to C. parapsilosis with comparisons to C. albicans. As
was previously reported about C. albicans (23), we now demonstrated that both signal-
ing proteins regulate the activation of NF-kB in C. parapsilosis-infected BMDMs.
Intriguingly, C. glabrata led to Syk phosphorylation without NF-kB in macrophage-like
cells (53). Therefore, C. parapsilosis resembles C. albicans rather than C. glabrata in reg-
ulating this transcriptional factor via the Syk/CARD9 pathway. Fitting with the role of
NF-kB in governing cytokine production (17, 39, 40, 54), we established that the cyto-
kine response of BMDMs to C. parapsilosis is influenced by Syk/CARD9 signaling.
Furthermore, we showed that Syk controls cytokine production of C. albicans-chal-
lenged BMDMs as already described in Syk2/2 or SHP-22/2 dendritic cells (DCs) (25, 33)
and various CARD92/2 cell types (21, 26, 28, 49). Notably, we found intact chemokine
secretion in C. parapsilosis-stimulated, but not in C. albicans-stimulated, Syk2/2
BMDMs, suggesting species-specific differences in terms of Syk activation. Another
interesting finding of our study was the CARD9-dependent, but Syk-independent,
FIG 8 Presence of MPO and CD681 or CD31 cells in histological kidney sections at 30 dpi. WtSyk, Syk
2/2, WtCARD9, and
CARD92/2 bone marrow chimeric mice were infected i.v. with C. parapsilosis (2  107 yeast cells/mouse) or C. albicans
(105 yeast cells/mouse) or mock infected with PBS (see Fig. S4B), and animals were euthanized at 30 dpi. Immune
staining for MPO, CD68, and CD3 (brown) was implemented to detect neutrophil granulocytes, macrophages, and T
cells, respectively. Note that 2 sets of microphotographs are shown for two CARD92/2 chimeras. Black arrows indicate
positivity for MPO, CD68, or CD3 staining. Scale, 100 mm.
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chemokine synthesis of BMDMs stimulated with C. parapsilosis. Similarly, a CARD9-de-
pendent, but Syk-independent, mechanism was previously described in BMDMs chal-
lenged with C. albicans hyphae (23). Although Toll-like receptors (TLRs) (55, 56) and nu-
cleotide-binding oligomerization domain 2 (NOD2) (22, 57) were proposed to signal
through CARD9, future investigations are required to elucidate Syk-independent sig-
naling through CARD9 in response to fungal stimuli.
Although multiple studies have covered the potential function of Syk and CARD9 in
the phagocytosis of zymosan (25, 28, 29, 32, 58) or “yeast particles” (30), the direct role
FIG 9 Cytokine production in kidneys following systemic infection with C. parapsilosis and C. albicans. (A to F) WtSyk and Syk
2/2 bone marrow chimeras
were infected i.v. with C. parapsilosis (2  107 yeast cells/mouse) or C. albicans (105 yeast cells/mouse) or mock infected with PBS (ctr), and animals were
euthanized at 2 or 30 dpi. Cytokines were measured from kidney homogenates with ELISA. (G to L) WtCARD9 and CARD9
2/2 bone marrow chimeras were
infected, and kidney homogenates were analyzed for cytokines similarly to panels A to F. Data are pooled from at least 2 independent experiments. Two-
way ANOVA was applied. *, P , 0.05; ***, P , 0.001; ****, P , 0.0001.
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of Syk in leukocytes or CARD9 in macrophages in ingesting live C. parapsilosis or C. albi-
cans cells has not been experimentally addressed to our knowledge. Our present
results revealed that BMDMs phagocytose both species in a Syk-dependent, yet
CARD9-independent, manner. Inhibition of Syk also hindered the phagocytosis of heat-
killed C. albicans, C. glabrata, and C. auris by neutrophils (46). Our data are in line with
the CARD9-independent internalization of C. albicans by human neutrophils and
monocytes (26, 49). Similarly, we found that phagosome acidification in BMDMs chal-
lenged with either C. parapsilosis or C. albicans was regulated by Syk, but not CARD9.
This supports the Syk-dependent phagosome acidification observed in RAW cells
treated with heat-killed C. albicans by reference 31 and that Syk, but not CARD9, was
required for proper maturation of C. albicans-containing phagosomes in macrophages
(47). Previous research also showed that neutrophils kill C. albicans in a Syk-dependent
manner (15, 46), while CARD9 was dispensable in this activity in murine neutrophils
(50). Likewise, elimination of C. parapsilosis by BMDMs relied on Syk, but not CARD9, in
our setting. Interestingly, human cells seem to differ from murine cells in that they can
exploit CARD9 to eliminate C. albicans (15, 26, 49).
Several studies reported that deficiency in Syk (33) or CARD9 (21, 26, 28, 36) in mice
leads to severe susceptibility to C. albicans (21, 26, 28, 33) or C. tropicalis (36) infections.
Our invasive candidiasis experiments now revealed that Syk and CARD9 in hematopoi-
etic cells contribute to systemic resistance to C. parapsilosis. Furthermore, we reaf-
firmed the crucial and almost immediate role of this pathway in the case of C. albicans.
Although excessive inflammation (cytokines, immunocyte infiltrates) was evident in
the kidneys of C. albicans-infected and C. parapsilosis-infected Syk- or CARD9-deficient
mice at 2 and 30 dpi, respectively, it likely does not contradict the decreased proinflam-
matory cytokine production of Syk2/2 or CARD92/2 myeloid cells but is, rather, the conse-
quence of unrestricted fungal presence triggering Syk/CARD9-independent signaling (e.g.,
TLR-MyD88 pathways). In the case of the C. parapsilosis challenge, immunocyte infiltrates
and elevated amounts of proinflammatory cytokines were more characteristic in the kidneys
of Syk2/2 animals than in those of CARD92/2 mice at 30 dpi. This may be the consequence
of the CARD9-dependent, but Syk-independent, chemokine production observed in C. para-
psilosis-treated macrophages that could allow for more efficacious leukocyte recruitment to
the site of infection in Syk2/2 chimeras than in CARD92/2 chimeras.
The mechanism through which Syk and CARD9 counteract C. albicans infections is
grounded in signaling initialized by Dectin-1, Dectin-2, Dectin-3, Mincle, and CR3 (12, 59–63).
However, it is unclear which receptors utilize the Syk/CARD9 pathway to provide the
observed in vivo protection against C. parapsilosis. Cell culture experiments with C. parapsilo-
sis revealed that Dectin-1 could regulate immune responses in vitro (10, 12, 42). In contrast,
phagocytosis of C. parapsilosis by human neutrophils was independent of Dectin-1 (64).
Furthermore, no dependence on Dectin-1 in long-term (21 dpi) clearance of C. parapsilosis
was reported (12), and our previous results demonstrated that the fungal load was unaf-
fected by Dectin-1 using several time points (1, 3, 7, 14, and 20 dpi) and multiple C. parapsilo-
sis strains (65). Therefore, it is tempting to hypothesize the involvement of Syk/CARD9-bound
PRRs other than Dectin-1 in systemic resistance against C. parapsilosis. Fitting with the crucial
role of Syk in B-cell development (66, 67) and that Syk was involved in more cellular processes
in response to Candida stimuli than CARD9 in our in vitro experiments, fungal burdens in
Syk2/2 chimeras tended to surpass those of CARD92/2 chimeras. Therefore, we propose that
Syk has a more prominent function in antifungal immunity than CARD9 against both Candida
species.
Notably, the excess of fungal burden in some organs (kidneys, livers, brain) of C.
parapsilosis-challenged Syk2/2 or CARD92/2 chimeras only surpassed that of WT chime-
ras dramatically at 30 dpi and, by this time, leukocyte infiltrates containing macrophages, neu-
trophils, and T cells and proinflammatory cytokine production were also evident in the kidneys
of mostly Syk2/2 chimeras. In contrast, the kidneys and brain of Syk2/2 and the kidneys of
CARD92/2 chimeras treated with C. albicans were marked by more than 100-fold higher colo-
nization and massive inflammation by 2 dpi. This is well before adaptive immunity could
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develop. Regarding systemic resistance, this may suggest that the Syk/CARD9 pathway plays a
greater role in innate immunity against C. albicans than C. parapsilosis. In our setting, it appears
that Syk- and CARD9-independent innate mechanisms initially exert some control over the
growth of C. parapsilosis in host tissues. However, it is possible that the absence of Syk and
CARD9 is sufficient for a failure in the development of adaptive immunity, and innate mecha-
nisms alone are unable to prevent the proliferation of host-adapted C. parapsilosis cells over
an extended period of infection. The notion that both proper innate and adaptive immunity
are required for the total elimination of this yeast is corroborated by our observation that
severe combined immunodeficient mice—infected according to the same methods as this
study—were unable to clear C. parapsilosis as efficiently as WT mice (unpublished data). The
species-specific kinetic patterns of fungal clearance by the Syk2/2 or CARD92/2 chimeras may
also arise from inherent differences between C. parapsilosis and C. albicans. For example, a
study found less beta-glucan in the cell wall of C. parapsilosis than that of C. albicans (12).
Accordingly, while the beta-glucan receptor Dectin-1 can play a crucial role in the resistance
against C. albicans (12, 59, 68), it seems less important against C. parapsilosis (12, 65). In the ab-
sence of Syk or CARD9, Dectin-1 signaling is damaged, promoting rapid initial expansion of C.
albicans yeast cells in the host. Subsequently, the formation of more virulent hyphae faces
only limited control without signaling from Dectin-2 and Dectin-3 (23, 62), allowing for fast
overgrowth as demonstrated in the kidneys of Syk2/2 or CARD92/2 chimeras at 2 dpi.
Extensive hyphal colonies of C. albicans comprise a potent inducer of inflammation through
mechanisms such as the production of the candidalysin toxin that induces host cell lysis (69).
In contrast, C. parapsilosis does not synthesize candidalysin nor form hyphae (7), which leaves
it prone to phagocytosis throughout the whole duration of infection. Additionally, this yeast is
less capable of triggering danger signals or inflammation (7, 38) and can actively hinder
inflammatory responses by enhancing IL-27 signaling (11). For example, IL-27 may downregu-
late IL-17 signaling and therefore attenuate neutrophil functions (11, 70, 71). All of these may
contribute to the gradual overgrowth of C. parapsilosis that eventually induces inflammatory
responses as observed at 30 dpi in the Syk2/2 or CARD92/2 chimeras. Delayed inflammation
in an immunocompromised host, such as the Syk2/2 or CARD92/2 chimeras, may serve to
grant C. parapsilosis a prolonged window for proliferation rather than leading to swift death.
As, unlike C. albicans, C. parapsilosis is horizontally transmissible (7, 72); this strategy may allow
for exploiting the host as a reservoir for propagation.
Before this study, directly Syk-dependent immunity to a nonalbicans Candida species in an
in vivo model was not reported. Recent investigations demonstrated that Syk mediates key
neutrophil responses to C. albicans, C. glabrata, and C. auris in vitro. Based on their data, the
authors suggested that “Syk may have differential roles depending on the fungal species” (46).
In accordance, our study is the first to show that Syk may regulate protective immune
responses to Candida infections species-specifically in vivo. CARD9 is also differentially involved
in immunity to Candida species (36), which our data confirm. Additionally, our study offers a
methodological novelty through the use of chimeras fully devoid of Syk or CARD9 selectively
in their hematopoietic systems to examine anti-Candida immune responses. The use of chime-
ras was necessitated by the perinatal mortality of fully Syk knockout (KO) mice (66, 67); there-
fore, we opted for CARD92/2 bone marrow chimeras instead of fully CARD9 KO animals for
better comparison. Using this model, phenotypes are better attributable to immunocytes than
a fully KO model would allow, as the expression of Syk/CARD9-dependent receptors is not re-
stricted to immunocytes (73, 74).
Our work prompts further investigations on exactly which PRRs and cell types are
responsible for Syk/CARD9-mediated functions in response to C. parapsilosis. While
Syk/CARD9 signaling confers protection against C. albicans largely via neutrophils (26,
33, 46), our ongoing research challenges the assumption that the susceptible pheno-
type of Syk2/2 or CARD92/2 chimeras infected with C. parapsilosis is a result of compro-
mised neutrophil functions (data not shown). Dissection of how this pathway regulates
adaptive immunity to C. parapsilosis and understanding on a molecular level of how
CARD9 may operate independently of Syk in myeloid cells must also be achieved in
the future. Finally, testing Syk and CARD9 agonists in the setting of experimental
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infections by common pathogenic Candida species will provide valuable information
on the curative prospects of Syk/CARD9 signaling on a species-specific scale.
Over the last decade, the modulation of the Syk/CARD9-dependent mechanisms
has been proposed as an approach to combat microbial infections (75), and the regula-
tion of Syk activity for therapeutic purposes has become reality (76). Our findings sup-
port ongoing efforts to target this pathway for anti-Candida immune therapy.
MATERIALS ANDMETHODS
Ethics statement. Animal experiments were carried out in accordance with the Hungarian national
(1998.XXVIII; 40/2013) and European (2010/63/EU) animal ethics guidelines. Procedures were approved
by the Animal Welfare Committees of the University of Szeged and the Semmelweis University as well as
the Hungarian National Animal Experimentation and Ethics Board. The license numbers for animal experiments
performed in this work were XIV-I-001/2150-4/2012 for the generation of bone marrow chimeras and XVI./
3646/2016 with the modification CSI/01/3646-6/2016 for the in vivo candidiasis experiments.
Mice. Syk-deficient, CARD9-deficient, and the respective wild-type bone marrow chimeric mice
(referred to as Syk2/2, WtSyk, CARD9
2/2, and WtCARD9 bone marrow chimeras) were used in this study for
the cultivation of macrophages and for in vivo experiments.
Syk2/2 and WtSyk bone marrow chimeric mice were generated by fetal liver transplantation as described
previously (77) with minor modifications. Briefly, heterozygous mice on the C57BL/6 genetic background har-
boring a deleted Syk allele (Syktm1Tyb) (66) were mated. Syk2/2 fetuses were distinguished based on their pete-
chiae morphology along with PCR (78) and used to obtain Syk2/2 bone marrow chimeras. Fetuses with normal
morphology (Syk1/1 and the Syk1/2 genotypes) were utilized for the generation of WtSyk chimeras. Embryos of
17 to 18 days were used to isolate fetal liver cells. The recipient mice (;8 to 10 weeks old) on the C57BL/6
genetic background were lethally irradiated by 11 Gy from a 137Cs source and subsequently injected intrave-
nously with fetal liver cell suspensions. Syk deficiency was checked 4 weeks after the transplantation based on
the defective B-cell differentiation in Syk-deficient hematopoietic systems (66). Blood was sampled and stained
with anti-B220 (clone RA3-6B2), anti-Ly6G (clone 1A8), and anti-CD45.2 (clone 104) (all from BD Biosciences)
antibodies for flow cytometric analysis. Bone marrow chimeras were considered Syk2/2 if, during the time of
detecting 500-neutrophil granulocytes (CD45.21Ly6G1 cells), the proportion of B cells (CD45.21 B2201 cells)
was no more than 8% within the total population consisting of B cells and neutrophils together.
Bone marrow transplantation was applied in order to generate CARD92/2 and WtCARD9 bone marrow
chimeras as described (79). Wild-type and CARD92/2 C57BL/6 mice [Card9tm1a(EUCOMM)Hmgu] homozygous
for the CD45.2 allele served as bone marrow donors, and a congenic strain carrying the CD45.1 allele on
the C57BL/6 genetic background (B6.SJL-Ptprca) was used as recipient. Bone marrow cells were intravenously
injected into previously lethally irradiated recipients (;8 to 20 weeks old). Four weeks later, peripheral blood
was stained with anti-Ly6G and anti-CD45.2 antibodies (both from BD Biosciences) and assessed by flow
cytometry. The transplantation was considered sufficient if over 98% of Ly6G1 neutrophils were CD45.21.
Cell cultures. The macrophage colony-stimulating factor (M-CSF)-producing L929 fibroblast cell line
(a kind gift from Csaba Vizler, Biological Research Centre, Szeged) was used to obtain L929-conditioned
medium. To this end, confluent cultures were incubated with nonsupplemented Dulbecco’s modified
Eagle’s medium (DMEM; Lonza) in 75-ml tissue culture flasks for 10 days. Cell culture supernatants were
subsequently sterile filtered, aliquoted, and kept at 220°C until utilization.
Based on previous studies (25, 80), primary bone marrow-derived macrophages (BMDMs) were cul-
tured from the bone marrows of 8- to 15-week-old female and male bone marrow chimeric mice in
BMDM medium (80% [vol/vol] DMEM supplemented with 10% heat-inactivated fetal bovine serum [FBS;
Lonza] and 1% penicillin-streptomycin mixture [Lonza]; 20% [vol/vol] L929-conditioned medium) for 7 to
9 days in 96-, 24-, or 12-well plates, according to the experiment. Fresh medium was added every other day.
We checked the functionality of the macrophage culturing method by immunostaining with anti-
CD11b (Sony) and anti-F4/80 antibodies (BioLegend) or isotype controls (Sony and BioLegend) followed
by flow cytometric analysis where CD11b1 F4/801 double-positive cells were considered macrophages
(81). As the proportion of these cells was over 80% in the case of all genotypes (data not shown), we
regarded the method as functional.
Fungal strains and preparation for experiments. C. parapsilosis GA1 (SZMC 8110), CLIB214 (SZMC
1560), CDC317, and C. albicans SC5314 (SZMC 1523) clinical isolates and a GFP-expressing derivative of
CLIB214 (genotype, CpNEUT5L/CpNEUT5L::pECpOE-GFP-N-N5L) were used in this study. All strains were main-
tained on YPD agar plates (1% yeast extract, 2% bactopeptone, 2% glucose, and 2% agar) at 4°C and were
refreshed monthly by streaking onto fresh medium followed by 2 days of incubation at 30°C. Before experi-
ments, Candida cells were grown overnight at 30°C in 2 ml liquid YPD medium (no agar), and 200ml of the sus-
pension was added to another 2 ml of liquid YPD for a second round of overnight incubation at 30°C. Yeast
cells were harvested by centrifugation, washed three times with phosphate-buffered saline (PBS), and counted
using a hemocytometer. Adequate cell concentrations determined by the multiplicity of infection (MOI) for the
individual experiments were set in PBS for in vivo infection experiments or in DMEM supplemented with 10%
heat-inactivated FBS and 1% penicillin-streptomycin mixture for in vitro coincubation experiments.
Nuclear translocation of NF-jB p65.Macrophages were infected with C. parapsilosis (MOI of 5:1) or
treated with LPS (1 mg/ml, positive control) in 12-well plates for 90 min. Cell culture medium was
refreshed on untreated control cells. At 75 min, DRAQ5 (Thermo Fisher Scientific) nuclear stain (2.5 mM)
was added to each well, and the incubation was continued for 15 min. Supernatants were discarded,
and wells were washed twice with PBS. Macrophages were trypsinized with TrypLE Express enzyme
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(Gibco) for 5 min and were suspended with 10% FBS-PBS. Staining of NF-kB p65 was carried out based
on an R&D Systems protocol (https://www.rndsystems.com/resources/protocols/flow-cytometry-protocol
-staining-intracellular-molecules-using-detergents). Briefly, centrifuged macrophages were fixed in 4% PFA-
PBS and washed twice. Cells were suspended in 100 ml 0.3% Triton X-100-PBS and were stained with 5 ml
Alexa Fluor 488-NF-kB p65 antibody (R&D Systems) for 30 min in the dark. After two further washing steps,
macrophages were loaded in the Amnis FlowSight imaging flow cytometer in 100ml PBS. Brightfield and fluores-
cence microscopic images of single macrophages were captured using laser excitation at 488 and 642 nm.
Nuclear Localization Wizard of the IDEAS 6.2 software was utilized to determine cell populations with NF-kB p65
translocated into nuclei.
Detection of cytokines by Proteome Profiler. BMDMs were infected with C. parapsilosis (GA1 strain;
MOI of 5:1) for 24 h in 24-well plates, and cell culture supernatants were pooled from at least 3 inde-
pendent experiments. The Proteome Profiler mouse cytokine array panel A kit (R&D Systems) was
applied for multiplex detection of cytokines according to the manufacturer’s instructions (https://
resources.rndsystems.com/pdfs/datasheets/ary006.pdf). A total of 700 ml pooled supernatant was used
for a single membrane. Chemiluminescence was visualized by Image Studio Digits 3.1.
Measurement of in vitro cytokine production by ELISA. BMDMs were cultured in 24-well plates
and infected with C. parapsilosis strains (MOI of 5:1) or the C. albicans strain (MOI of 1:25) for 24 h. The
concentrations of TNF-a, KC, MIP1-a, and MIP-2 in cell culture supernatants were determined by com-
mercial ELISA kits (R&D Systems; catalog nos. DY410, DY453, DY450, and DY452, respectively) in accord-
ance with the manufacturer’s instructions. OD measurement was carried out using the SPECTROstar
Nano microplate reader (BMG Labtech), and data were analyzed with the MARS data analysis software.
Phagocytosis assay. The experiment was carried out as described (38, 82). In short, yeast cells
stained with Alexa Fluor 488 succinimidyl ester (Invitrogen) or a GFP-expressing transformant derived
from the CLIB214 C. parapsilosis isolate were cocultured with macrophages (MOI of 5:1) in 12-well cell culture
plates. In the case of C. parapsilosis strains, coincubation times were 15 min and 120 min. As hyphae formation
may interfere with phagocytosis and hinder the quantification of ingested yeast cells, 15-min and 30-min time
points were applied for C. albicans infections to avoid hyphenation. Macrophages were washed twice with PBS,
trypsinized, and suspended in FBS-PBS. Pelleted cells were resuspended in 100ml PBS and loaded into the Amnis
FlowSight imaging flow cytometer. Singlet macrophages were gated and monitored with white light and
488 nm laser illumination. The IDEAS 6.2 software was used for data analysis. Alexa Fluor 4881 or GFP1 macro-
phages were defined as the phagocytosing cell population. Microphotographs of individual macrophages were
submitted to the Spot Count Wizard to determine the average number of ingested yeast cells per macrophage
within the phagocytosing population.
Phagosome acidification. The method used by Papp et al. (83) was modified in this experiment.
Candida cells were dually labeled with Alexa Fluor 488 succinimidyl ester and the pH-sensitive fluorescent dye
pHrodo Red succinimidyl ester (Invitrogen) in Hanks’ balanced salt solution. The GFP-expressing CLIB214 strain
was only stained with pHrodo Red succinimidyl ester. Macrophages were infected with the labeled yeast cells
(MOI of 5:1) in 12-well cell culture plates for 15 min. Cocultures were then treated and loaded into the Amnis
FlowSight imaging flow cytometer as in the phagocytosis assay. Singlet macrophages were examined with white
light and 488 nm laser illumination. A compensation matrix was applied to eliminate the partially overlapping
emission of pHrodo Red and Alexa Fluor 488 or GFP. We used the IDEAS 6.2 software for data analysis. While
pHrodo Red gains bright fluorescence in acidified phagosomes, the emission of Alexa Fluor 488 is independent
of cellular localization. Thus, phagosome acidification efficacy was calculated as follows:
proportion of pHrodoRed1macrophages
proportion of Alexa Fluor 4881orGFP1macrophages
 100%
Elimination of C. parapsilosis by macrophages. Macrophages were coincubated with different C.
parapsilosis strains (MOI of 5:1) in 24-well plates in triplicates for 3 h. Macrophage-free control wells with
identical numbers of yeast cells were also used. After incubation, macrophages were disrupted by add-
ing distilled water and forcibly pulling the culture through a 26-gauge needle 5 times. Serially diluted
lysates were plated on YPD plates and incubated at 30°C for 2 days. The number of CFU was determined,




In vivo infection of bone marrow chimeras and fungal burden of tissues.Mice were injected with
C. parapsilosis (2  107 yeast cells/100 ml PBS per mouse) or C. albicans (2  105 yeast cells/100 ml PBS
per mouse) via the lateral tail vein. C. parapsilosis-infected animals were euthanized 2, 5, 7, and 30 dpi,
while C. albicans-infected ones were sacrificed on day 2. Blood was sampled from the retro-orbital plexus
or the caudal vena cava and was plated on YPD agar plates. Spleens, kidneys, livers, and brains were sur-
gically collected, weighed, and homogenized in 2 ml PBS using a TT-30K digital handheld homogenizer
(Hercuvan). Homogenates were plated on YPD agar plates. CFU were counted after 2 days of incubation
at 30°C, and fungal burden was calculated as CFU/ml blood or CFU/g tissue for the assessed organs.
Cytokine content in kidneys. Mice were infected with C. parapsilosis or C. albicans as described in
the previous paragraph or mock infected with 100 ml PBS. Kidneys were harvested 2 and 30 (in the case
of C. parapsilosis) dpi and were homogenized. The LEGENDplex bead-based immunoassay approach
(BioLegend) was used for multiplex identification of cytokines in the kidney homogenates using a BD
FACSAria Fusion device (BD Biosciences) and the BD FACSDiva software.
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Histopathology of kidneys. Mice were infected with C. parapsilosis or C. albicans as described
above. Kidneys were collected and fixed in 4% paraformaldehyde (PFA)-PBS 2 and 30 (in the case of C.
parapsilosis) dpi, and periodic acid-Schiff (PAS)-stained sections were prepared to detect fungal elements
and leukocyte infiltrates. Preparations labeled with rabbit anti-MPO (Abcam), anti-CD68, and anti-CD3
(Boster Biological) primary antibodies and stained with kits implementing anti-rabbit secondary antibod-
ies (Abcam, catalog no. ab209101; Boster Biological, catalog no. SV0002-1) were also made to visualize
the presence of neutrophil granulocytes, macrophages, and T cells, respectively.
Quantification and statistical analysis. Significance was determined at P , 0.05. All in vitro assays
were analyzed by paired Student's t test. Mann-Whitney tests were used for the evaluation of fungal bur-
den, and two-way analysis of variance (ANOVA) was applied for the assessment of the kidney cytokine
content. Tests were performed and diagrams were created with the GraphPad Prism 6.0 software.
Statistical details and tests are shown in the figure legends.
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